Authors

  • Ra'no Boboeva
    Bukhara State Medical Institute named after Abu Ali ibn Sino.
  • Orzigul Bekmurodova
    Bukhara State Medical Institute named after Abu Ali ibn Sino.

DOI:

https://doi.org/10.71337/inlibrary.uz.ijms.135131

Keywords:

Conjunctivitis metabolic syndrome complex treatment influence of metabolic syndrome diabetic retinopathy insulin resistance

Abstract

Metabolic syndrome is a combination of pathological conditions, including insulin resistance, arterial hypertension, hyperlipidemia, and abdominal obesity, which significantly affect various body systems. One of the important aspects of metabolic syndrome is its impact on eye health, especially on the development of inflammatory diseases such as conjunctivitis. Conjunctivitis against the background of metabolic syndrome can have various clinical manifestations, including redness, itching, tearing, and eye swelling. The pathogenesis of these diseases includes both the direct effect of metabolic disorders and the secondary weakening of immune defense. Endocrine and metabolic disorders contribute to changes in the structure of tear fluid, which increases susceptibility to inflammation and infections. A comprehensive approach to treating conjunctivitis against the background of metabolic syndrome includes both systemic and local therapeutic methods. The most important areas of treatment are the correction of metabolic disorders using drugs aimed at reducing blood sugar levels, improving lipid metabolism, and normalizing blood pressure. Local treatment of conjunctivitis includes the appointment of anti-inflammatory and antiseptic medications, as well as the use of medications to improve the condition of the tear film. Thus, effective treatment of conjunctivitis in patients with metabolic syndrome requires an individual approach, which includes both the correction of the underlying disease and the use of specific therapy to reduce inflammation and prevent complications.

background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Au

gu

st

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

COMPREHENSIVE APPROACH TO THE COURSE AND TREATMENT OF

CONJUNCTIVITIS AGAINST THE BACKGROUND OF METABOLIC

SYNDROME

Boboeva Ra'no Rahimovna

Bukhara State Medical Institute named after Abu Ali ibn Sino. Bukhara, Uzbekistan. e-mail:

boboyeva.rano@bsmi.uz

Bekmurodova Orzigul Kamolovna

Bukhara State Medical Institute named after Abu Ali ibn Sino. Bukhara, Uzbekistan. e-mail:

bekmurodovaorzigul@bsmi.uz

Annotation.

Metabolic syndrome is a combination of pathological conditions, including

insulin resistance, arterial hypertension, hyperlipidemia, and abdominal obesity, which

significantly affect various div systems. One of the important aspects of metabolic

syndrome is its impact on eye health, especially on the development of inflammatory

diseases such as conjunctivitis. Conjunctivitis against the background of metabolic

syndrome can have various clinical manifestations, including redness, itching, tearing, and

eye swelling. The pathogenesis of these diseases includes both the direct effect of metabolic

disorders and the secondary weakening of immune defense. Endocrine and metabolic

disorders contribute to changes in the structure of tear fluid, which increases susceptibility to

inflammation and infections.

A comprehensive approach to treating conjunctivitis against the background of metabolic

syndrome includes both systemic and local therapeutic methods. The most important areas

of treatment are the correction of metabolic disorders using drugs aimed at reducing blood

sugar levels, improving lipid metabolism, and normalizing blood pressure. Local treatment

of conjunctivitis includes the appointment of anti-inflammatory and antiseptic medications,

as well as the use of medications to improve the condition of the tear film. Thus, effective

treatment of conjunctivitis in patients with metabolic syndrome requires an individual

approach, which includes both the correction of the underlying disease and the use of

specific therapy to reduce inflammation and prevent complications.

Keywords:

Conjunctivitis, metabolic syndrome, complex treatment, influence of metabolic

syndrome, diabetic retinopathy, insulin resistance

Аннотация.

Метаболический

синдром

представляет

собой

совокупность

патологических состояний, включающих инсулинорезистентность, артериальную

гипертензию, гиперлипидемию и абдоминальное ожирение, которые оказывают

значительное влияние на различные системы организма. Одним из важных аспектов

метаболического синдрома является его влияние на здоровье глаз, особенно на

развитие воспалительных заболеваний, таких как конъюнктивит. Конъюнктивиты на

фоне метаболического синдрома могут иметь различные клинические проявления,

включая покраснение, зуд, слезотечение и отечность век. Патогенез этих заболеваний

включает как прямое воздействие метаболических нарушений, так и вторичное

ослабление иммунной защиты. Эндокринные и обменные нарушения способствуют

изменению структуры слезной жидкости, что увеличивает предрасположенность к

воспалению и инфекциям.

Комплексный подход к лечению конъюнктивитов на фоне метаболического синдрома

включает как системные, так и местные терапевтические методы. Важнейшими

направлениями лечения являются коррекция метаболических нарушений с


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Au

gu

st

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

использованием препаратов, направленных на снижение уровня сахара в крови,

улучшение липидного обмена и нормализацию артериального давления. Местное

лечение

конъюнктивита

включает

назначение

противовоспалительных

и

антисептических препаратов, а также использование препаратов для улучшения

состояния слезной пленки. Таким образом, эффективное лечение конъюнктивита у

пациентов с метаболическим синдромом требует индивидуального подхода, который

включает как коррекцию основного заболевания, так и использование специфической

терапии для уменьшения воспаления и предотвращения осложнений.

Ключевые слова:

Конъюнктивит, метаболический синдром, комплексное лечение,

влияние

метаболического

синдрома,

диабетическая

ретинопатия,

инсулинорезистентность.

Аннотация.

Метаболик синдром организмнинг турли тизимларига сезиларли таъсир

кўрсатадиган инсулин қаршилиги, артериал гипертензия, гиперлипидемия ва

абдоминал семизликни ўз ичига олган патологик ҳолатлар тўпламидир. Метаболик

синдромнинг муҳим жиҳатларидан бири унинг кўз саломатлигига, айниқса

конъюнктивит каби яллиғланиш касалликларинингривожланишига таъсиридир.

Метаболик синдром фонидаги конъюнктивитлар турли хил клиник кўринишларга эга

бўлиши мумкин, жумладан, қизариш, қичишиш, кўз ёшланиши ва қовоқларнинг

шишиши. Ушбу касалликларнинг патогенези метаболик бузилишларнинг бевосита

таъсирини ҳам, иммунитет ҳимоясининг иккиламчи заифлашувини ҳам ўз ичига

олади. Эндокрин ва алмашинув бузилишлари суюқлик таркибининг ўзгаришига олиб

келади.

Метаболик синдром фонидаги конъюнктивитларни даволашга комплекс ёндашув ҳам

тизимли, ҳам маҳаллий терапевтик усулларни ўз ичига олади. Даволашнинг энг

муҳим йўналишлари қондаги қанд миқдорини камайтириш, липид алмашинувини

яхшилаш ва қон босимини нормаллаштиришга қаратилган дори-дармонларни қўллаш

орқали метаболик бузилишларни тузатишдир. Конъюнктивитни маҳаллий даволаш

яллиғланишга қарши ва антисептик дориларни тайинлаш, кўз ёши пардасининг

ҳолатини яхшилаш учун дорилардан фойдаланишни ўз ичига олади. Шундай қилиб,

метаболик синдром билан оғриган беморларда конъюнктивитни самарали даволаш

асосий касалликни тузатишни ҳам, яллиғланишни камайтириш ва асоратларнинг

олдини олиш учун махсус терапиядан фойдаланишни ҳам ўз ичига олган индивидуал

ёндашувни талаб қилади.

Калит сўзлар:

Конъюнктивит, метаболик синдром, комплекс даволаш, метаболик

синдром таъсири, диабетик ретинопатия, инсулинрезистентлик.

Metabolic syndrome (MS) is a group of metabolic disorders that includes insulin resistance,

hypertension, dyslipidemia, obesity, and high blood sugar. These disorders are closely

related to the development of various diseases, including eye diseases such as conjunctivitis.

In this regard, it is important to consider a comprehensive approach to the diagnosis and

treatment of conjunctivitis against the background of metabolic syndrome, taking into

account the impact of general metabolic disorders on the condition of the visual organs. The

topic of a comprehensive approach to the course and treatment of conjunctivitis against the


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Au

gu

st

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

background of metabolic syndrome is very relevant, given modern trends in the field of

medicine and health care.

Metabolic syndrome (MS) includes a number of metabolic disorders such as obesity,

hypertension, dyslipidemia, insulin resistance, which can affect various organs and systems,

including the eyes.

Increase in metabolic syndrome

. In recent decades, there has been an increase in the

number of patients with metabolic syndrome, which is associated with a deterioration in

lifestyle, poor nutrition, physical inactivity and stress. This directly affects the occurrence of

concomitant diseases, including eye diseases. The impact of MS on the immune system.

Metabolic syndrome is accompanied by inflammatory processes in the div, which can lead

to a change in the immune response, including an increased risk of developing inflammation

in the eyes, such as conjunctivitis. Risks of worsening conjunctivitis. People with metabolic

syndrome often have problems with microcirculation, which can make it difficult to treat

inflammatory diseases, including conjunctivitis. In addition, diabetes and other metabolic

disorders can increase the likelihood of infection and slow healing. The need for a

comprehensive approach to treatment. Given the relationship between metabolic syndrome

and eye diseases, treatment of conjunctivitis should be comprehensive. This includes not

only the use of local drugs (antibacterial, antiviral, anti-inflammatory), but also the

correction of metabolic disorders with the help of medications, diet, exercise and other

methods aimed at improving the general condition of the patient.

Early detection and prevention

. Prevention and timely detection of both metabolic

syndrome and eye diseases are important aspects in preventing the development of

complications. The use of screening methods to detect both MS and eye diseases allows for

the effective prevention of disease progression. Metabolic syndrome has a significant impact

on eye health, contributing to the development of various diseases. One such disease is

conjunctivitis, an inflammation of the conjunctiva, the membrane that covers the front of the

eyeball and the inside of the eyelids. Signs of conjunctivitis include redness, itching,

swelling, and discharge from the eyes. However, in patients with metabolic syndrome, the

disease can be more severe and prolonged, which is associated with a number of factors:

Insulin resistance can contribute to the development of chronic inflammatory processes,

which can complicate the recovery process during infections. Systemic inflammation,

characteristic of metabolic syndrome, increases the likelihood of developing conjunctivitis,

especially in conditions of a weakened immune response. Dry eyes and impaired

lacrimation are also common in patients with metabolic syndrome, which may be an

additional risk factor for the development of conjunctivitis.

Diagnosis of conjunctivitis in patients with metabolic syndrome requires a comprehensive

approach. In addition to traditional diagnostic methods, such as examination and

microbiological examination of eye discharge, the following aspects must be taken into

account: Assessing the patient's general health, identifying signs of metabolic syndrome

(high blood pressure, excess weight, lipid metabolism disorders, increased blood glucose

levels). Assessing the presence of concomitant eye diseases, such as dry eye syndrome,

which can worsen the course of conjunctivitis. Inflammation tests, including C-reactive

protein (CRP) levels and other inflammatory markers, to assess the degree of systemic

inflammation. Treatment of conjunctivitis in patients with metabolic syndrome requires not


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Au

gu

st

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

only an effect on conjunctival inflammation, but also correction of the underlying metabolic

disease. Treatment should be comprehensive and include the following stages: Anti-

inflammatory drugs for the treatment of conjunctivitis can be used both locally (eye drops,

ointments) and systemically anti-inflammatory drugs. The use of steroidal and non-steroidal

anti-inflammatory drugs may be justified in severe forms of inflammation. Antibiotics and

antiseptics in case of bacterial infection, broad-spectrum antibiotics may be prescribed. It is

important to consider the possible tendency of patients with metabolic syndrome to

microflora disturbance, which may affect the choice of drugs. Moisturizing drops for dry eye

syndrome it is important to use moisturizing preparations to maintain the normal condition

of the mucous membrane of the eyes. Eye hygiene following hygiene recommendations and

regularly cleaning the eyelids from dirt helps reduce inflammation and improve healing

processes. Treatment of metabolic syndrome Correction of metabolic disorders is of key

importance in the treatment of conjunctivitis against the background of metabolic syndrome.

It is important to work in the following areas:

Control of blood sugar levels. To improve your health and reduce inflammation, you need to

control your blood glucose levels through diet, exercise, and medication (such as metformin

or insulin).

Correction of lipid metabolism. The use of statins to reduce cholesterol levels in the blood

can reduce inflammation in the div and in the eyes.

Normalization of blood pressure. The use of antihypertensive drugs to control blood

pressure helps reduce the risk of vascular diseases of the eyes.

Diet and physical activity. Eating a balanced diet that includes antioxidants and anti-

inflammatory foods, as well as regular physical activity, can help improve overall

metabolism. A patient’s lifestyle plays an important role in the treatment of both metabolic

syndrome and conjunctivitis.

Lifestyle recommendations include:

• Stopping smoking and limiting alcohol consumption, as these factors can worsen both eye

inflammation and metabolic disorders.

• Reducing stress through relaxation techniques or psychological support.

A comprehensive approach to the treatment of conjunctivitis against the background of

metabolic syndrome includes not only local therapy, but also correction of the underlying

disease. It is important to consider the impact of metabolic disorders on the course of eye

diseases and to apply an integrated approach, including drug treatment, lifestyle changes and

continuous monitoring of the patient's health. Thus, attention to metabolic disorders in the

context of the treatment of eye diseases helps to increase the effectiveness of therapy and

improve the quality of life of patients.

Literatures:


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Au

gu

st

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

1. K.Lekhanont et al. Effect of topical olopatadine and epinastine in the botulinum toxin B-

induced mouse model of dry eye. // J Ocul Pharmacol Ther. 2007 Feb; 23(1): 83-8. D
2. Pan Q. et al. Autologous serum eye drops for dry eye //Cochrane Database of Systematic

Reviews. – 2017. – №. 2.
3. Bielory L., Lien K. W., Bigelsen S. Efficacy and tolerability of newer antihistamines in

the treatment of allergic conjunctivitis //Drugs. – 2005. – Т. 65. – №. 2. – С. 215-228.
4. Azari A. A., Barney N. P. Conjunctivitis: a systematic review of diagnosis and treatment

//Jama. – 2013. – Т. 310. – №. 16. – С. 1721-1730.
5. Owen CG, Shah A, Henshaw K, et al. Topical treatments for seasonal allergic

conjunctivitis: systematic review and meta-analysis of efficacy and effectiveness. //Br J Gen

Pract. – 2004. – v.54(503). – P.451-456.
6. Hwang D. G. et al. A phase III, placebo controlled clinical trial of 0.5% levofloxacin

ophthalmic solution for the treatment of bacterial conjunctivitis //British journal of

ophthalmology. – 2003. – Т. 87. – №. 8. – С. 1004-1009.

7.Boboeva Ranо Rakhimovna. Improvement of Methods of Treatment of Retinal

Angiopathies of Various Etiologies: //Journal of Natural and Medical Education Year

2024;3(2).

8.Бобоева Раъно Рахимовна. Совершенствование методов лечения ангиопатий

сетчатки различной этиологии. //Journal of science in medicine and life. 2024; с. 61-65.

9. Бобоева Раъно Рахимовна. Комплексный подход к течению и лечению

конъюнктивитов на фоне метаболического синдрома .// world scientific research

journal volume-38_issue-1_april-2025 ,84-90ст

References

K.Lekhanont et al. Effect of topical olopatadine and epinastine in the botulinum toxin B-induced mouse model of dry eye. // J Ocul Pharmacol Ther. 2007 Feb; 23(1): 83-8. D

Pan Q. et al. Autologous serum eye drops for dry eye //Cochrane Database of Systematic Reviews. – 2017. – №. 2.

Bielory L., Lien K. W., Bigelsen S. Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis //Drugs. – 2005. – Т. 65. – №. 2. – С. 215-228.

Azari A. A., Barney N. P. Conjunctivitis: a systematic review of diagnosis and treatment //Jama. – 2013. – Т. 310. – №. 16. – С. 1721-1730.

Owen CG, Shah A, Henshaw K, et al. Topical treatments for seasonal allergic conjunctivitis: systematic review and meta-analysis of efficacy and effectiveness. //Br J Gen Pract. – 2004. – v.54(503). – P.451-456.

Hwang D. G. et al. A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis //British journal of ophthalmology. – 2003. – Т. 87. – №. 8. – С. 1004-1009.

Boboeva Ranо Rakhimovna. Improvement of Methods of Treatment of Retinal Angiopathies of Various Etiologies: //Journal of Natural and Medical Education Year 2024;3(2).

Бобоева Раъно Рахимовна. Совершенствование методов лечения ангиопатий сетчатки различной этиологии. //Journal of science in medicine and life. 2024; с. 61-65.

Бобоева Раъно Рахимовна. Комплексный подход к течению и лечению конъюнктивитов на фоне метаболического синдрома .// world scientific research journal volume-38_issue-1_april-2025 ,84-90ст